BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
416.54
+0.58 (0.14%)
At close: Nov 13, 2026, 4:00 PM EST
413.00
-3.54 (-0.85%)
After-hours: Nov 13, 2026, 7:57 PM EST
BeOne Medicines AG Employees
BeOne Medicines AG had 12,000 employees as of September 30, 2026. The number of employees increased by 1,000 or 9.09% compared to the same quarter last year.
Employees
12,000
Change (1Y)
1,000
Growth (1Y)
9.09%
Revenue / Employee
$537,162
Profits / Employee
$84,991
Market Cap
47.58B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2026 | 12,000 | 1,000 | 9.09% | 12,000 | 0 |
| Jun 30, 2026 | 12,000 | 1,000 | 9.09% | 12,000 | 0 |
| Mar 31, 2026 | 12,000 | 1,000 | 9.09% | 12,000 | 0 |
| Dec 31, 2025 | 12,000 | 1,000 | 9.09% | 12,000 | 0 |
| Sep 30, 2025 | 11,000 | 1,000 | 10.00% | 11,000 | 0 |
| Jun 30, 2025 | 11,000 | 1,000 | 10.00% | 11,000 | 0 |
| Mar 31, 2025 | 11,000 | 1,000 | 10.00% | 11,000 | 0 |
| Dec 31, 2024 | 11,000 | 400 | 3.77% | 11,000 | 0 |
| Jun 30, 2024 | 10,000 | 600 | 6.38% | 10,000 | 0 |
| Mar 31, 2024 | 10,000 | 600 | 6.38% | 10,000 | 0 |
| Dec 31, 2023 | 10,600 | 1,600 | 17.78% | 10,600 | 0 |
| Mar 31, 2023 | 9,400 | 1,100 | 13.25% | 9,400 | 0 |
| Dec 31, 2022 | 9,000 | 1,000 | 12.50% | 9,000 | 0 |
| Sep 30, 2022 | 9,000 | 1,400 | 18.42% | 9,000 | 0 |
| Mar 31, 2022 | 8,300 | 2,900 | 53.70% | 8,300 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Regeneron Pharmaceuticals | 15,343 |
| BioNTech SE | 7,807 |
| Moderna | 4,700 |
| Genmab | 3,244 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| argenx SE | 1,863 |
| Insmed | 1,664 |
ONC News
- 1 day ago - BeOne Medicines price target raised to $476 from $465 at Morgan Stanley - TheFly
- 8 days ago - BeOne Medicines price target raised to $477 from $454 at TD Cowen - TheFly
- 8 days ago - BeOne Medicines price target raised to $465 from $425 at Morgan Stanley - TheFly
- 8 days ago - BeOne Medicines Q3 Earnings Call Highlights - MarketBeat
- 8 days ago - BeOne Medicines price target raised to $448 from $420 at Truist - TheFly
- 8 days ago - BeOne Medicines price target raised to $463 from $405 at Citizens - TheFly
- 8 days ago - BeOne Medicines price target raised to $446 from $415 at Barclays - TheFly
- 9 days ago - Compared to Estimates, BeOne Medicines Ltd. - Sponsored ADR (ONC) Q3 Earnings: A Look at Key Metrics - Nasdaq